Molecular mechanisms underlying human adipose tissue-derived stromal cells differentiation into a hepatocyte-like phenotype

Digestive and Liver Disease

Volumn 42, Issue 12, 2010, Pages 895-901

  Saulnier, Nathalie ^a   Piscaglia, Anna Chiara ^a   Puglisi, Maria Ausiliatrice ^a   Barba, Marta ^a   Arena, Vincenzo ^a   Pani, Giovambattista ^b   Alfieri, Sergio ^a   Gasbarrini, Antonio ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Adipose stromal cells; Hepatocyte differentiation; Mesenchymal epithelial transition (MET); Microarray

Indexed keywords

ADIPOSE TISSUE; ADULT; ARTICLE; BIODEGRADATION; CASE REPORT; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSDIFFERENTIATION; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; INNATE IMMUNITY; LIVER CELL; LIVER FUNCTION; MALE; MESENCHYME CELL; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN METABOLISM; STROMA CELL; TRANSCRIPTION REGULATION;

ADIPOSE TISSUE; CELL DIFFERENTIATION; HEPATOCYTES; HUMANS; PHENOTYPE; STROMAL CELLS;

EID: 78650288413     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.04.013     Document Type: Article

References (30)

1. Stravitz R.T., Kramer D.J. Medscape. Management of acute liver failure. Nat Rev Gastroenterol Hepatol 2009, 6:542-553.
2. Lake B.G., Paine A.J. The effect of hepatocyte culture conditions on cytochrome P450 linked drug metabolising enzymes. Biochem Pharmacol 1982, 31:2141-2144.
3. Petersen B.E., Bowen W.C., Patrene K.D., et al. Bone marrow as a potential source of hepatic oval cells. Science 1999, 284:1168-1170.
4. Theise N.D., Badve S., Saxena R., et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 2000, 31:235-240.
5. Lee K.D., Kuo T.K., Whang-Peng J., et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004, 40:1275-1284.
6. Zuk P.A., Zhu M., Mizuno H., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7:211-228.
7. Liu T.M., Martina M., Hutmacher D.W., et al. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells 2007, 25:750-760.
8. Kern S., Eichler H., Stoeve J., et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006, 24:1294-1301.
9. Seo M.J., Suh S.Y., Bae Y.C., et al. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun 2005, 328:258-264.
10. Taléns-Visconti R., Bonora A., Jover R., et al. Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. World J Gastroenterol 2006, 12:5834-5845.
11. Banas A., Teratani T., Yamamoto Y., et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 2007, 46:219-228.
12. Yamamoto Y., Banas A., Murata S., et al. A comparative analysis of the transcriptome and signal pathways in hepatic differentiation of human adipose mesenchymal stem cells. FEBS J 2008, 275:1260-1273.
13. Saulnier N., Lattanzi W., Puglisi M.A., et al. Mesenchymal stromal cells multipotency and plasticity: induction toward the hepatic lineage. Eur Rev Med Pharmacol Sci 2009, 13:71-79.
14. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
15. Heubach J.F., Graf E.M., Leutheuser J., et al. Electrophysiological properties of human mesenchymal stem cells. J Physiol 2004, 554:659-672.
16. Van den Abbeele A., De Corte V., Van Impe K., et al. Downregulation of gelsolin family proteins counteracts cancer cell invasion in vitro. Cancer Lett 2007, 255:57-70.
17. Grotendorst G.R., Chang T., Seppa H.E., et al. Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells. J Cell Physiol 1982, 113:261-266.
18. Huber M.A., Kraut N., Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005, 17:548-558.
19. de Wolf C.J., Cupers R.M., Bertina R.M., et al. The constitutive expression of anticoagulant protein S is regulated through multiple binding sites for Sp1 and Sp3 transcription factors in the protein S gene promoter. J Biol Chem 2006, 281:17635-17643.
20. Schmeidler-Sapiro K.T., Ratnoff O.D., Gordon E.M. Mitogenic effects of coagulation factor XII and factor XIIa on HepG2 cells. Proc Natl Acad Sci USA 1991, 88:4382-4385.
21. Matsuo R., Ohkohchi N., Murata S., et al. Platelets strongly induce hepatocyte proliferation with IGF-1 and HGF in vitro. J Surg Res 2008, 145:279-286.
22. Lu B., Sims P.J., Wiedmer T., et al. Expression of the phospholipid scramblase (PLSCR) gene family during the acute phase response. Biochim Biophys Acta 2007, 1771:1177-1185.
23. Hodgson E., Levi P.E. Species, organ and cellular variation in the flavin-containing monooxygenase. Drug Metabol Drug Interact 1988, 6:219-233.
24. Oesch F., Herrero M.E., Hengstler J.G. Metabolic detoxification: implications for thresholds. Toxicol Pathol 2000, 28:382-387.
25. Ziemann C., Schäfer D., Rüdell G., et al. The cyclooxygenase system participates in functional mdr1b overexpression in primary rat hepatocyte cultures. Hepatology 2002, 35:579-588.
26. Hay E.D. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 2005, 233:706-720.
27. Hugo H., Ackland M.L., Blick T., et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007, 213:374-383.
28. Zeisberg M., Hanai J., Sugimoto H., et al. BMP-7 counteracts TGF-beta1-induced epithelial-tomesenchymal transition and reverses chronic renal injury. Nat Med 2003, 9:964-968.
29. Abreu J.G., Ketpura N.I., Reversade B., et al. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 2002, 4:599-604.
30. Lee J.M., Dedhar S., Kalluri R., et al. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006, 172:973-981.